关注
Janet Coller
Janet Coller
Senior Lecturer in Pharmacology, the University of Adelaide
在 adelaide.edu.au 的电子邮件经过验证
标题
引用次数
引用次数
年份
Pharmacogenetics of opioids
AA Somogyi, DT Barratt, JK Coller
Clinical Pharmacology & Therapeutics 81 (3), 429-444, 2007
4182007
MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy
S Elad, KKF Cheng, RV Lalla, N Yarom, C Hong, RM Logan, J Bowen, ...
Cancer 126 (19), 4423-4431, 2020
4142020
Implications of central immune signaling caused by drugs of abuse: mechanisms, mediators and new therapeutic approaches for prediction and treatment of drug dependence
JK Coller, MR Hutchinson
Pharmacology & therapeutics 134 (2), 219-245, 2012
1982012
The influence of CYP2B6, CYP2C9 and CYP2D6 genotypes on the formation of the potent antioestrogen Z4hydroxytamoxifen in human liver
JK Coller, N Krebsfaenger, K Klein, K Endrizzi, R Wolbold, T Lang, ...
British journal of clinical pharmacology 54 (2), 157-167, 2002
1722002
ABCB1 genetic variability and methadone dosage requirements in opioiddependent individuals
JK Coller, DT Barratt, K Dahlen, MH Loennechen, AA Somogyi
Clinical Pharmacology & Therapeutics 80 (6), 682-690, 2006
1652006
CYP2D6 and CYP3A4 involvement in the primary oxidative metabolism of hydrocodone by human liver microsomes
MR Hutchinson, A Menelaou, DJR Foster, JK Coller, AA Somogyi
British journal of clinical pharmacology 57 (3), 287-297, 2004
1502004
Irinotecan-induced gastrointestinal dysfunction and pain are mediated by common TLR4-dependent mechanisms
HR Wardill, RJ Gibson, YZA Van Sebille, KR Secombe, JK Coller, ...
Molecular cancer therapeutics 15 (6), 1376-1386, 2016
1492016
Role of active metabolites in the use of opioids
JK Coller, LL Christrup, AA Somogyi
European journal of clinical pharmacology 65, 121-139, 2009
1362009
Attenuation of microglial and IL-1 signaling protects mice from acute alcohol-induced sedation and/or motor impairment
Y Wu, EL Lousberg, LM Moldenhauer, JD Hayball, SA Robertson, ...
Brain, behavior, and immunity 25, S155-S164, 2011
872011
Inhibiting the TLR4MyD88 signalling cascade by genetic or pharmacological strategies reduces acute alcoholinduced sedation and motor impairment in mice
Y Wu, EL Lousberg, LM Moldenhauer, JD Hayball, JK Coller, KC Rice, ...
British journal of pharmacology 165 (5), 1319-1329, 2012
802012
Naloxone-precipitated morphine withdrawal behavior and brain IL-1β expression: comparison of different mouse strains
L Liu, JK Coller, LR Watkins, AA Somogyi, MR Hutchinson
Brain, behavior, and immunity 25 (6), 1223-1232, 2011
722011
Systematic review of agents for the management of cancer treatment-related gastrointestinal mucositis and clinical practice guidelines
JM Bowen, RJ Gibson, JK Coller, N Blijlevens, P Bossi, N Al-Dasooqi, ...
Supportive Care in Cancer 27, 4011-4022, 2019
692019
The bidirectional interaction of the gut microbiome and the innate immune system: Implications for chemotherapyinduced gastrointestinal toxicity
KR Secombe, JK Coller, RJ Gibson, HR Wardill, JM Bowen
International journal of cancer 144 (10), 2365-2376, 2019
672019
CYP2B6*6 allele and age substantially reduce steadystate ketamine clearance in chronic pain patients: impact on adverse effects
Y Li, KA Jackson, B Slon, JR Hardy, M Franco, L William, P Poon, ...
British journal of clinical pharmacology 80 (2), 276-284, 2015
672015
Distribution of microsomal epoxide hydrolase in humans: an immunohistochemical study in normal tissues, and benign and malignant tumours
JK Coller, P Fritz, UM Zanger, I Siegle, M Eichelbaum, HK Kroemer, ...
The histochemical journal 33, 329-336, 2001
642001
Association between the DRD2 A1 allele and response to methadone and buprenorphine maintenance treatments
DT Barratt, JK Coller, AA Somogyi
American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 141 …, 2006
632006
The combined impact of CYP2C19 and CYP2B6 pharmacogenetics on cyclophosphamide bioactivation
NA Helsby, CY Hui, MA Goldthorpe, JK Coller, MC Soh, PJ Gow, ...
British journal of clinical pharmacology 70 (6), 844-853, 2010
602010
ABCB1 haplotype and OPRM1 118A > G genotype interaction in methadone maintenance treatment pharmacogenetics
DT Barratt, JK Coller, R Hallinan, A Byrne, JM White, DJR Foster, ...
Pharmacogenomics and personalized medicine, 53-62, 2012
592012
Comparison of (S)mephenytoin and proguanil oxidation in vitro: contribution of several CYP isoforms
Coller, Somogyi, Bochner
British journal of clinical pharmacology 48 (2), 158-167, 1999
571999
OPRM1 A118G genotype fails to predict the effectiveness of naltrexone treatment for alcohol dependence
JK Coller, S Cahill, C Edmonds, AL Farquharson, M Longo, R Minniti, ...
Pharmacogenetics and genomics 21 (12), 902-905, 2011
512011
系统目前无法执行此操作,请稍后再试。
文章 1–20